🔬 GYNECOLOGIC PATHOLOGY · MASTERCLASS · 2026

WHO · FIGO · ICCR · NCCN · MOLECULAR DIAGNOSTICS

Gynecologic Pathology
Masterclass 2026

Contemporary issues in classification, diagnostic criteria & ancillary testing — covering ovarian, endometrial, cervical, vulvovaginal & mesenchymal gynecologic pathology.

⚡ Instant Digital Access — Complete Gynecologic Pathology Review

Includes: 20 Expert Video Lectures & Roundtables + PDF Documents | Google Drive Delivery

📚 Course Overview

Gynecologic pathology is undergoing important shifts in nomenclature, classification and diagnostic thresholds. The forthcoming sixth edition of the WHO Classification of Tumours of Female Reproductive Organs, together with evolving FIGO, ICCR and NCCN frameworks, makes a current understanding of these changes essential for every practicing pathologist.

This Gynecologic Pathology Masterclass explores the practical implications of new terminology, molecular findings and biomarker data for diagnosis, risk stratification, prognostication and clinical decision-making. Featuring 20 expert-led sessions including 4 faculty roundtables on diagnostic grey areas, the course provides an in-depth update across ovarian, endometrial, cervical, vulvovaginal and mesenchymal gynecologic pathology.

Trainees and practicing pathologists will familiarize themselves with new terminology, recognize newly characterized entities, and adapt to the evolving criteria that influence patient management — from molecular markers and biomarker testing to refined risk stratification and precision medicine in gynecologic oncology.

🔬 Eight Core Areas

Comprehensive coverage across gynecologic pathology

📦 Learning Objectives

• ✓ Apply WHO classification, FIGO staging, ICCR reporting and NCCN guidelines to gynecologic pathology practice
• ✓ Appraise emerging knowledge on endometrial, upper genital tract and mesenchymal gynecologic neoplasia
• ✓ Describe updated lower genital tract classifications and recommended terminology
• ✓ Identify when molecular testing is essential for mesenchymal, sex-cord stromal or gestational neoplasia diagnosis
• ✓ Explain the role of biomarker testing in ovarian, endometrial and cervical cancer diagnosis, prognosis and management

📋 Complete Curriculum — 20 Sessions

Expert-led topics & faculty roundtables

Ovarian Pathology · 4 Sessions

• 1. Pathology of Ovarian Epithelial Tumors
• 2. Molecular Testing in Ovarian Cancer
• 3. Ovarian Epithelial Lesions
• 4. Ovarian Non-Epithelial Lesions

Non-Epithelial & Mesenchymal · 4 Sessions

• 5. Pathology of Non-Epithelial Ovarian Tumors
• 6. Gynecologic Mesenchymal Neoplasia
• 7. Mesenchymal Neoplasms
• 8. Molecular Testing in Mesenchymal and Gestational Trophoblastic Lesions

Endometrial Pathology · 3 Sessions

• 9. Endometrial Pathology
• 10. Molecular Testing in Endometrial Cancer
• 11. Endometrium

Cervical & Lower Genital Tract · 5 Sessions

• 12. Cervix
• 13. Pathology of the Uterine Cervix
• 14. Vulvo-Vaginal Pathology
• 15. Vulva
• 16. Biomarker Testing in Lower Genital Tract Neoplasia

Faculty Roundtables — Diagnostic Grey Areas · 4 Sessions

• 17. Roundtable: Grey Areas in Endometrial Pathology
• 18. Roundtable: Grey Areas in Ovarian Pathology
• 19. Roundtable: Grey Areas in Non-Epithelial Gynecologic Neoplasia
• 20. Roundtable: Grey Areas in Lower Genital Tract Pathology

🎯 Who Is This For?

Created for practicing and future specialists in diagnostic pathology.

Master Contemporary Gynecologic Pathology

20 expert sessions + PDF documents · Instant access · Lifetime

Access the Complete Program